As of 2026-04-11, the Relative Valuation of Biosergen AB (BIOSGN.ST) is (12.38) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 10.10 SEK, the upside of Biosergen AB based on Relative Valuation is -222.5%.
The range of the Relative Valuation is (14.24) - (8.35) SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 1.4x - 2.0x | 1.7x |
| Forward P/E multiples | 3.5x - 5.2x | 4.4x |
| Fair Price | (14.24) - (8.35) | (12.38) |
| Upside | -241.0% - -182.6% | -222.5% |
| Date | P/E |
| 2026-04-07 | -2.69 |
| 2026-04-02 | -8.55 |
| 2026-04-01 | -8.55 |
| 2026-03-31 | -8.26 |
| 2026-03-30 | -8.16 |
| 2026-03-27 | -8.85 |
| 2026-03-26 | -8.90 |
| 2026-03-25 | -8.90 |
| 2026-03-24 | -8.80 |
| 2026-03-23 | -9.14 |
| 2026-03-19 | -9.14 |
| 2026-03-18 | -9.14 |
| 2026-03-17 | -8.90 |
| 2026-03-16 | -9.14 |
| 2026-03-13 | -8.99 |
| 2026-03-12 | -9.39 |
| 2026-03-11 | -9.39 |
| 2026-03-10 | -9.39 |
| 2026-03-09 | -9.04 |
| 2026-03-06 | -9.29 |
| 2026-03-04 | -9.39 |
| 2026-03-03 | -9.39 |
| 2026-03-02 | -9.39 |
| 2026-02-27 | -9.39 |
| 2026-02-26 | -9.34 |
| 2026-02-25 | -9.39 |
| 2026-02-24 | -9.63 |
| 2026-02-23 | -9.53 |
| 2026-02-20 | -9.78 |
| 2026-02-19 | -10.17 |
| 2026-02-18 | -10.41 |
| 2026-02-17 | -10.02 |
| 2026-02-16 | -10.61 |
| 2026-02-13 | -10.66 |
| 2026-02-12 | -10.61 |
| 2026-02-11 | -10.31 |
| 2026-02-10 | -10.31 |
| 2026-02-09 | -10.66 |
| 2026-02-06 | -11.10 |
| 2026-02-05 | -10.66 |
| 2026-02-04 | -11.00 |
| 2026-02-03 | -10.66 |
| 2026-02-02 | -10.36 |
| 2026-01-30 | -10.26 |
| 2026-01-29 | -10.90 |
| 2026-01-28 | -10.51 |
| 2026-01-27 | -10.12 |
| 2026-01-26 | -10.12 |
| 2026-01-23 | -10.17 |
| 2026-01-22 | -10.17 |